178 related articles for article (PubMed ID: 37150157)
21. Melatonin Receptor Agonists for Delirium Prevention.
Walker CK; Gales MA
Ann Pharmacother; 2017 Jan; 51(1):72-78. PubMed ID: 27539735
[TBL] [Abstract][Full Text] [Related]
22. Melatonin or Ramelteon for Delirium Prevention in the Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aiello G; Cuocina M; La Via L; Messina S; Attaguile GA; Cantarella G; Sanfilippo F; Bernardini R
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675363
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of perioperative melatonin for postoperative delirium in patients undergoing surgery: a systematic review and meta-analysis.
Shin HW; Kwak JS; Choi YJ; Kim JW; You HS; Shin HJ; Jang YK
J Int Med Res; 2024 May; 52(5):3000605241239854. PubMed ID: 38735057
[TBL] [Abstract][Full Text] [Related]
24. Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study.
Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
Int J Psychiatry Med; 2014; 47(2):97-104. PubMed ID: 25084796
[TBL] [Abstract][Full Text] [Related]
25. Ramelteon for delirium prevention in hospitalized patients: An updated meta-analysis and trial sequential analysis of randomized controlled trials.
Yu CL; Carvalho AF; Thompson T; Tsai TC; Tseng PT; Tu YK; Yang SN; Yang FC; Chang CH; Hsu CW; Hsu TW; Liang CS
J Pineal Res; 2023 Apr; 74(3):e12857. PubMed ID: 36726202
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotics in the Treatment of Delirium in Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Carayannopoulos KL; Alshamsi F; Chaudhuri D; Spatafora L; Piticaru J; Campbell K; Alhazzani W; Lewis K
Crit Care Med; 2024 Jul; 52(7):1087-1096. PubMed ID: 38488422
[TBL] [Abstract][Full Text] [Related]
27. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
Tian Y; Qin Z; Han Y
Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
[TBL] [Abstract][Full Text] [Related]
28. Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol.
Foster J; Burry LD; Thabane L; Choong K; Menon K; Duffett M; Cheung A; Guenette M; Chimunda T; Rose L
Syst Rev; 2016 Nov; 5(1):199. PubMed ID: 27881185
[TBL] [Abstract][Full Text] [Related]
29. Melatonin and melatonergic agents for the prevention of postoperative delirium: A meta-analysis of randomized placebo-controlled trials.
Wang CM; Zhou LY
Asian J Surg; 2022 Jan; 45(1):27-32. PubMed ID: 34092473
[TBL] [Abstract][Full Text] [Related]
30. Effects of Ramelteon on the Prevention of Postoperative Delirium in Older Patients Undergoing Orthopedic Surgery: The RECOVER Randomized Controlled Trial.
Oh ES; Leoutsakos JM; Rosenberg PB; Pletnikova AM; Khanuja HS; Sterling RS; Oni JK; Sieber FE; Fedarko NS; Akhlaghi N; Neufeld KJ
Am J Geriatr Psychiatry; 2021 Jan; 29(1):90-100. PubMed ID: 32532654
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and harms of pharmacological interventions for the treatment of delirium in adults in intensive care units after cardiac surgery: a systematic review.
Leigh V; Stern C; Elliott R; Tufanaru C
JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2020-2074. PubMed ID: 31449136
[TBL] [Abstract][Full Text] [Related]
32. Exogenous Melatonin for Delirium Prevention: a Meta-analysis of Randomized Controlled Trials.
Chen S; Shi L; Liang F; Xu L; Desislava D; Wu Q; Zhang J
Mol Neurobiol; 2016 Aug; 53(6):4046-4053. PubMed ID: 26189834
[TBL] [Abstract][Full Text] [Related]
33. Ramelteon is Not Associated With Improved Outcomes Among Critically Ill Delirious Patients: A Single-Center Retrospective Cohort Study.
Thom R; Bui M; Rosner B; Teslyar P; Levy-Carrick N; Wolfe D; Klompas M
Psychosomatics; 2019; 60(3):289-297. PubMed ID: 30193784
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials.
Zhang Q; Gao F; Zhang S; Sun W; Li Z
Sleep Breath; 2019 Dec; 23(4):1059-1070. PubMed ID: 31119597
[TBL] [Abstract][Full Text] [Related]
35. Marked improvement in delirium with ramelteon: five case reports.
Furuya M; Miyaoka T; Yasuda H; Yamashita S; Tanaka I; Otsuka S; Wake R; Horiguchi J
Psychogeriatrics; 2012 Dec; 12(4):259-62. PubMed ID: 23279149
[TBL] [Abstract][Full Text] [Related]
36. Interventions for preventing intensive care unit delirium in adults.
Herling SF; Greve IE; Vasilevskis EE; Egerod I; Bekker Mortensen C; Møller AM; Svenningsen H; Thomsen T
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009783. PubMed ID: 30484283
[TBL] [Abstract][Full Text] [Related]
37. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.
McGowan NM; Kim DS; de Andres Crespo M; Bisdounis L; Kyle SD; Saunders KEA
CNS Drugs; 2022 Apr; 36(4):345-363. PubMed ID: 35305257
[TBL] [Abstract][Full Text] [Related]
38. A Rapid Systematic Review of Pharmacologic Sleep Promotion Modalities in the Intensive Care Unit.
Heavner MS; Louzon PR; Gorman EF; Landolf KM; Ventura D; Devlin JW
J Intensive Care Med; 2024 Jan; 39(1):28-43. PubMed ID: 37403460
[No Abstract] [Full Text] [Related]
39. The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review.
Wang HR; Woo YS; Bahk WM
Int Clin Psychopharmacol; 2016 Nov; 31(6):301-6. PubMed ID: 27294772
[TBL] [Abstract][Full Text] [Related]
40. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
